Cencora
COR · NYSE
$343.27+$3.27 (+0.96%)TodayMarket closed ·
Prev close $340.00
EPS: actual vs estimate
Beat the estimate in 7 of the last 8 quarters, by 3.3% on average
Next report: , before the market opens
- Quarter
- Q4 FY26
- EPS estimate
- $4.57
- Revenue estimate
- $87.95B
Reported EPS
Estimated EPS
| Quarter | Estimate | Reported | Surprise |
|---|---|---|---|
| Q2 FY26 | $4.39 | $4.48 | +2.0% |
| Q1 FY26 | $4.86 | $4.75 | −2.3% |
| Q4 FY25 | $3.82 | $3.84 | +0.4% |
| Q3 FY25 | $3.88 | $4.00 | +3.2% |
| Q2 FY25 | $4.15 | $4.42 | +6.6% |
| Q1 FY25 | $3.54 | $3.73 | +5.4% |
| Q4 FY24 | $3.25 | $3.34 | +2.7% |
| Q3 FY24 | $3.25 | $3.34 | +2.8% |
Earnings calls
- 2026 Global Healthcare Conference
- Morgan Stanley 24th Annual Global Healthcare Conference
- Wells Fargo 21st Annual Healthcare Conference
- COR - Earnings call Q3 2026
- Bank of America Global Healthcare Conference 2026
- COR - Earnings call Q2 2026
- Leerink Global Healthcare Conference 2026
- Barclays 28th Annual Global Healthcare Conference
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.